LivQ-box® Parameters in the Diagnosis of Liver Inflammation

NCT06802731 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 365

Last updated 2025-01-31

No results posted yet for this study

Summary

To evaluate the correlation between LivQ-box® parameters carried by iLivTouch and liver inflammation in patients with NAFLD, as well as the diagnostic value of liver inflammation of different severity levels.

Conditions

  • Liver Inflammation
  • Fatty Liver Disease

Sponsors & Collaborators

  • Beijing Tsinghua Changgeng Hospital

    collaborator OTHER
  • Wuxi Hisky Medical Technology Co Ltd

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2025-03-31
Completion
2025-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06802731 on ClinicalTrials.gov